To provide Biosimilar
products around the world.
We specialize in developing biosimilar drugs. By providing our biosimilars to the medical fraternity, we are committed to contribute to the society and people by subsidizing medical spending to reduce financial burden of patients; while maintaining highest product quality
YL Biologics Limited is a joint venture between Yoshindo Inc. (headquartered in Toyama, Japan) and Lupin Limited (headquartered in Mumbai, India).
- Obtainment of Manufacturing and Sales Approval for Etanercept Biosimilar, Anti-rheumatoid Arthritis Agent ”read more” link to press release PDF.
- Teijin, Yoshindo and YL Biologics Enter Into a Marketing Alliance Agreement for Etanercept Biosimilar, Anti-rheumatoid Arthritis Agent ”read more” link to press release PDF.
Corporate Headquarters: 12F, Hamacho Center Building2-31-1,
Nihonbashi Hamacho, Chuo-ku, Tokyo 103-0007